Grant: Collaborative Research and Development Grants
McGill University
$92,908.00
Mixed-Reality Platform for Simulation and Synthesis of Multi-Modal Hallucinations with Applications to Schizophrenia Treatment_x000d_
EF 2020-21
Résumé
Treating patients with schizophrenia for auditory hallucinations has traditionally required multiple trials of antipsychotic medications with approximately one in three patients being resistant to antipsychotic therapies. An alternative called Avatar Therapy has been developed and shown to effectively reduce the distress and helplessness associated with auditory hallucinations.
While Avatar Therapy shows great promise, there are many open questions as to the requirements for optimal delivery of this treatment. Similarly, many potential enhancements to how avatars are rendered to the patient remain to be tested. Exploration of these questions and enhancements requires development of a virtual reality platform that offers to the therapist the ability to easily adjust various parameters of the avatar(s). We will iteratively design, implement, and test such a platform, and then apply the knowledge gained to an augmented reality version of the platform suitable for use outside of the therapist's office. The resulting intelligent medical device will offer the possibility of providing therapeutic benefits to patients in their day-to-day activities.
_x000d_Le traitement d'hallucinations chez les patients atteints de schizophrénie requiert typiquement de nombreux essais de médicaments antipsychotiques. De plus, environ un patient sur trois atteints de schizophrénie est résistant aux traitements antipsychotiq
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
543332-2019
Name nom
Cooperstock, Jeremy
Department département
Electrical and Computer Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
92908
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2716
Research subject group en
Information technology
Research subject group fr
Technologie de l'information
Research subject en
Virtual reality and related simulations
Research subject fr
Réalité virtuelle et simulations connexes
Installment
inst:2 - 2
Partie
1
Nb partie
2
Application title
Mixed-Reality Platform for Simulation and Synthesis of Multi-Modal Hallucinations with Applications to Schizophrenia Treatment_x000d_
Keyword
NSERC
Application summary
Treating patients with schizophrenia for auditory hallucinations has traditionally required multiple trials of antipsychotic medications with approximately one in three patients being resistant to antipsychotic therapies. An alternative called Avatar Therapy has been developed and shown to effectively reduce the distress and helplessness associated with auditory hallucinations.
While Avatar Therapy shows great promise, there are many open questions as to the requirements for optimal delivery of this treatment. Similarly, many potential enhancements to how avatars are rendered to the patient remain to be tested. Exploration of these questions and enhancements requires development of a virtual reality platform that offers to the therapist the ability to easily adjust various parameters of the avatar(s). We will iteratively design, implement, and test such a platform, and then apply the knowledge gained to an augmented reality version of the platform suitable for use outside of the therapist's office. The resulting intelligent medical device will offer the possibility of providing therapeutic benefits to patients in their day-to-day activities.
_x000d_Le traitement d'hallucinations chez les patients atteints de schizophrénie requiert typiquement de nombreux essais de médicaments antipsychotiques. De plus, environ un patient sur trois atteints de schizophrénie est résistant aux traitements antipsychotiq